Literature DB >> 34413948

Novel Substituted Piperidine-2,6-dione Derivatives for Treating Sickle Cell Disease and β-Thalassemia.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34413948      PMCID： PMC8366006          DOI： 10.1021/acsmedchemlett.1c00392

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.632


× No keyword cloud information.
  4 in total

Review 1.  Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing.

Authors:  Athina Tampaki; Eleni Gavriilaki; Christos Varelas; Achilles Anagnostopoulos; Efthymia Vlachaki
Journal:  Blood Rev       Date:  2021-01-21       Impact factor: 8.250

2.  A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy.

Authors:  Sherif M Badawy; Usman Beg; Robert I Liem; Sonali Chaudhury; Alexis A Thompson
Journal:  Blood Adv       Date:  2021-01-26

Review 3.  Sickle cell disease: progress towards combination drug therapy.

Authors:  Betty S Pace; Athena Starlard-Davenport; Abdullah Kutlar
Journal:  Br J Haematol       Date:  2021-01-20       Impact factor: 6.998

Review 4.  Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials.

Authors:  Muhammad Ashar Ali; Asrar Ahmad; Hafsa Chaudry; Wajeeha Aiman; Sobia Aamir; Muhammad Yasir Anwar; Anam Khan
Journal:  Exp Hematol       Date:  2020-08-22       Impact factor: 3.084
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.